Hepatitis c Trials in San Antonio, United States
Conditions / Hepatitis c / San Antonio, United States
Hepatitis c is a medical condition with active clinical research programs worldwide.
75 total trials for this combination
Showing top 10 of 75 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02607800 | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy | COMPLETED | PHASE3 |
| NCT00495768 | Reducing Depressive Symptoms During HCV Therapy: A Randomized Study | UNKNOWN | NA |
| NCT00535847 | A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy | COMPLETED | PHASE2 |
| NCT01297270 | Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2) | COMPLETED | PHASE3 |
| NCT01732848 | A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189) | COMPLETED | — |
| NCT01485991 | TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy | COMPLETED | PHASE3 |
| NCT00627926 | A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV) | COMPLETED | PHASE3 |
| NCT01318694 | Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants | COMPLETED | PHASE3 |
| NCT01492504 | Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial | COMPLETED | — |
| NCT02607735 | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy | COMPLETED | PHASE3 |